{
  "trial_id": "NCT04113915",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "ITP patients received triple therapy or steroids only more than 18 years old",
      "label": "met",
      "evidence": "patient text"
    },
    {
      "criterion": "ITP patients received triple therapy or steroids only more than 18 years old",
      "label": "met",
      "evidence": "patient text"
    }
  ],
  "exclusion": [
    {
      "criterion": "All ITP patient less than 18 years old or treated with other regimens except triple therapy or steroids",
      "label": "not_met",
      "evidence": "patient text"
    },
    {
      "criterion": "Patients with other bleeding disorders",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "ITP patients with known viral hepatitis B & C infection before triple therapy",
      "label": "unknown",
      "evidence": "none"
    }
  ],
  "notes": "Patient has chronic HCV infection, but direct antiviral drugs were added to his treatment 6 months ago. He is on IFN (100 mg/week) plus RBV (400 mg/day) combination therapy for the past 9 months.",
  "_meta": {
    "topic_id": "27",
    "trial_id": "NCT04113915",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}